Immucell (ICCC) Asset Utilization Ratio (2011 - 2026)

Immucell (ICCC) has reported Asset Utilization Ratio for 16 consecutive years, with 0.6 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio fell 6.42% year-over-year to 0.6; the trailing twelve-month figure through Jun 2026 stood at 0.6 (down 6.42% YoY), and the FY2025 full-year result was 0.63, up 5.86% from the prior year.
• Asset Utilization Ratio eased to 0.6 in Q2 2026 per ICCC's latest filing, from 0.63 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.64 in Q2 2025 and bottomed at 0.28 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.44 in 2022.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slumped 31.15% in 2023, then surged 111.21% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.41 in 2022, then tumbled by 31.15% to 0.28 in 2023, then soared by 111.21% to 0.59 in 2024, then advanced by 5.87% to 0.63 in 2025, then dropped by 4.16% to 0.6 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.6, 0.63, and 0.63 for Q2 2026, Q4 2025, and Q3 2025 respectively.